Structural basis of SARS-CoV-2 Omicron immune evasion and receptor engagement

Science, Ahead of Print.

21h

Vaccination before or after SARS-CoV-2 infection leads to robust humoral response and antibodies that effectively neutralize variants

Science Immunology, Ahead of Print.

21h

The SARS-CoV-2 monoclonal antibody combination, AZD7442, is protective in non-human primates and has an extended half-life in humans

Science Translational Medicine, Ahead of Print.

21h

SARS-CoV-2 Beta variant infection elicits potent lineage-specific and cross-reactive antibodies

Science, Ahead of Print.

22h

SARS-CoV-2 Omicron variant: Antibody evasion and cryo-EM structure of spike protein–ACE2 complex

Science, Ahead of Print.

5d

Cannabidiol inhibits SARS-CoV-2 replication through induction of the host ER stress and innate immune responses

Science Advances, Ahead of Print.

5d

It’s not too late

Science, Ahead of Print.

1w

Neutralization of SARS-CoV-2 Omicron by BNT162b2 mRNA vaccine–elicited human sera

Science, Ahead of Print.

1w

Early non-neutralizing, afucosylated antibody responses are associated with COVID-19 severity

Science Translational Medicine, Ahead of Print.

1w

Longitudinal analysis reveals high prevalence of Epstein-Barr virus associated with multiple sclerosis

Science, Ahead of Print.

2w